Jinli Ma

1.3k total citations
55 papers, 913 citations indexed

About

Jinli Ma is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinli Ma has authored 55 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 23 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinli Ma's work include Breast Cancer Treatment Studies (24 papers), Advanced Radiotherapy Techniques (11 papers) and Breast Lesions and Carcinomas (11 papers). Jinli Ma is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Advanced Radiotherapy Techniques (11 papers) and Breast Lesions and Carcinomas (11 papers). Jinli Ma collaborates with scholars based in China, United States and France. Jinli Ma's co-authors include Lawrence B. Marks, Xiaomao Guo, Xiaoli Yu, Zhaozhi Yang, Jessica L. Hubbs, Zheng Chang, F Yin, John P. Kirkpatrick, Zhiheng Wang and Xin Mei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jinli Ma

53 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinli Ma China 17 400 351 328 235 211 55 913
L. Caravatta Italy 19 325 0.8× 256 0.7× 226 0.7× 88 0.4× 418 2.0× 71 886
Edy Ippolito Italy 17 493 1.2× 280 0.8× 235 0.7× 175 0.7× 393 1.9× 80 902
Amy Chang China 15 457 1.1× 272 0.8× 191 0.6× 114 0.5× 292 1.4× 28 940
Hyung Jun Yoo South Korea 17 522 1.3× 463 1.3× 235 0.7× 108 0.5× 262 1.2× 34 1.2k
C. Sugie Japan 21 731 1.8× 538 1.5× 449 1.4× 91 0.4× 124 0.6× 70 1.1k
Michael S. Binkley United States 12 378 0.9× 187 0.5× 159 0.5× 210 0.9× 202 1.0× 45 688
Imogen Locke United Kingdom 16 301 0.8× 298 0.8× 246 0.8× 288 1.2× 208 1.0× 39 798
Lucia Di Brina Italy 15 485 1.2× 293 0.8× 286 0.9× 82 0.3× 197 0.9× 45 815
Carla Hajj United States 18 295 0.7× 156 0.4× 151 0.5× 148 0.6× 551 2.6× 85 916
Renuka Malik United States 15 694 1.7× 322 0.9× 284 0.9× 112 0.5× 234 1.1× 60 1.0k

Countries citing papers authored by Jinli Ma

Since Specialization
Citations

This map shows the geographic impact of Jinli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinli Ma more than expected).

Fields of papers citing papers by Jinli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinli Ma. The network helps show where Jinli Ma may publish in the future.

Co-authorship network of co-authors of Jinli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jinli Ma. A scholar is included among the top collaborators of Jinli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinli Ma. Jinli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhaozhi, Jin Meng, Xin Mei, et al.. (2024). Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases. JAMA Oncology. 10(3). 335–335. 10 indexed citations
2.
Zhang, Xiaomeng, Li Zhang, Shi Wei, et al.. (2024). Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trial. Clinical and Translational Radiation Oncology. 50. 100882–100882. 1 indexed citations
3.
Pan, Zhe, Li Zhang, Wei Shi, et al.. (2024). Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism. Advanced Science. 12(5). e2413103–e2413103. 1 indexed citations
4.
Zhang, Li, Wei Shi, Zhaozhi Yang, et al.. (2024). CXCR6 expression correlates with radiotherapy response and immune context in triple-negative breast cancer–experimental studies. International Journal of Surgery. 110(8). 4695–4707. 3 indexed citations
6.
Lima, Ernesto A. B. F., Chengyue Wu, Angela M. Jarrett, et al.. (2023). Assessing the identifiability of model selection frameworks for the prediction of patient outcomes in the clinical breast cancer setting. Journal of Computational Science. 69. 102006–102006. 4 indexed citations
7.
Jin, Meng, Xiaomeng Zhang, Li Zhang, et al.. (2023). The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy. Journal of Oncology. 2023. 1–10. 5 indexed citations
8.
Wang, Xuanyi, Kairui Jin, Jurui Luo, et al.. (2022). Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery. Cancer Medicine. 11(14). 2755–2766. 3 indexed citations
9.
Zhang, Li, Xiaomeng Zhang, Jurui Luo, et al.. (2021). Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?. Breast Cancer Research and Treatment. 190(2). 277–286. 6 indexed citations
10.
Zhang, Xiaomeng, Xingxing Chen, Jinli Ma, et al.. (2021). Clinicopathological Characteristics of Breast Ductal Carcinoma In Situ: An Analysis of Chinese Population of 617 Patients. Journal of Oncology. 2021. 1–6. 1 indexed citations
11.
Luo, Jurui, Kairui Jin, Xuanyi Wang, et al.. (2020). Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients. Cancer Medicine. 9(7). 2427–2434. 8 indexed citations
13.
Ma, Jinli, et al.. (2016). Clinical evaluation of Ginkgo biloba extract for diabetic retinopathy. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Zhou, Zhirui, Xingxing Chen, Ruping Zhao, et al.. (2016). HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo. Oncotarget. 7(29). 45186–45198. 59 indexed citations
15.
Ma, Jinli, et al.. (2016). Efficacy of Chinese medicine formula for central serous chorioretinopathy. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Ma, Jinli, Jiang Xie, Jian Chen, et al.. (2013). Post mastectomy linac IMRT irradiation of chest wall and regional nodes: dosimetry data and acute toxicities. Radiation Oncology. 8(1). 81–81. 43 indexed citations
17.
Marks, Lawrence B., Constance Cirrincione, Thomas J. FitzGerald, et al.. (2009). Impact of High-Dose Chemotherapy on the Ability to Deliver Subsequent Local–Regional Radiotherapy for Breast Cancer: Analysis of Cancer and Leukemia Group B Protocol 9082. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1305–1313. 18 indexed citations
18.
Ma, Jinli, Zheng Chang, Zhiheng Wang, et al.. (2009). ExacTrac X-ray 6 degree-of-freedom image-guidance for intracranial non-invasive stereotactic radiotherapy: Comparison with kilo-voltage cone-beam CT. Radiotherapy and Oncology. 93(3). 602–608. 75 indexed citations
19.
Miles, Edward F., Nicole Larrier, Chris R. Kelsey, et al.. (2008). Intensity-Modulated Radiotherapy for Resected Mesothelioma: The Duke Experience. International Journal of Radiation Oncology*Biology*Physics. 71(4). 1143–1150. 71 indexed citations
20.
Ma, Jinli, S. Zhou, Jessica L. Hubbs, et al.. (2008). The Association between RT-induced Changes in Lung Tissue Density and Global Lung Function. International Journal of Radiation Oncology*Biology*Physics. 72(1). S456–S456. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026